Comparing two groups from lowest to highest scan rate6, patients who scanned more frequently using the FreeStyle Libre systems* spent 43% more Time In Range.
Real-World Data
Analysing the impact of the FreeStyle Libre 2 Portfolio on the lives of real users
Outcomes for people with diabetes
The FreeStyle Libre 2 Portfolio is making a real impact on outcomes for people with diabetes.
Increases Time in Range1
Improves quality of life2
Reduces hypoglycaemia1,3
Decreases HbA1c4
Real-World Data
More frequent use of the FreeStyle Libre 2 systems* increases Time in Range5
Frequent use of the FreeStyle Libre 2 system also resulted in patients spending 26% less Time Below Range (<54 mg/dL)5
The FreeStyle Libre 2 system is clinically proven to significantly reduce hypoglycaemia in T1D1 and T2D3 patients
Increased testing frequency is sustained over time with the FreeStyle Libre 2 system.7
Clinical Evidence
Clinical benefits for a broad range of T1D and
T2D patients.
References & Disclaimers
Images are for illustrative purposes only. Not real patient, data or healthcare professional.
* FreeStyle Libre systems refers to the FreeStyle Libre system
1. Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kr ger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388(10057):2254-2263.
2. Fokkert M, van Dijk P, Edens M, et al. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diab Res Care. 2019. https://doi:10.1136/bmjdrc-2019-000809.
3. Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8(1): 55-73.
4. Yaron M, Roitman E, Aharon-Hananel G, et al. Effect of flash glucose monitoring technology on glycemic control and treatment satisfaction in patients with type 2 diabetes. Diabetes Care. 2019;42(7):1178-1184. 2020;43(2):389-397.
5. Lang J, Jangam S, Dunn T, Hayter G. Expanded real-world use reaffirms strong correlation between scanning frequency of flash glucose monitoring and glucose control [Poster 972]. Diabetes. 2019;68(suppl 1). https://doi.org/10.2337/db19-972-P.
6. Comparing 2 groups from lowest to highest scan rate (3.6 and 39.5 scans/day).
7. Jangam S, Dunn T, Xu Y, Hayter G, Ajjan R. Flash glucose monitoring improves glycemia in higher-risk patients: a longitudinal, observational study under real-life settings. BMJOpen Diab Res Care 2019;7:e000611. DOl:10.1136/bmjdrc-2018-000611.